Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Anti-MMP-9 MAb wins U.S. orphan drug designation for gastric cancer

July 20, 2015

Amgen reports phase II trial results for blinatumomab in Ph+ ALL

July 17, 2015

Immunocore conducts European life sciences' largest private financing

July 17, 2015

FDA grants orphan drug designation to DPX-Survivac for ovarian cancer

July 16, 2015

Dendritic cell vaccination induces tumor-specific immune responses

July 16, 2015

Canadian trial investigates novel tumor-targeted oncolytic virus vaccine

July 13, 2015

Genentech's atezolizumab reduces tumor size in phase II urothelial bladder cancer study

July 13, 2015

Monopar partners with Cancer Research UK and Cancer Research Technology on HuATN-658

July 13, 2015

FDA grants fast track designation to Toca-511 & Toca-FC for recurrent glioma

July 10, 2015

Prima Biomed receives positive scientific advice from the EMA for IMP-321

July 8, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...